About Contact Us Careers

Zoster Treatment Market Trends

Request Free Sample Copy

Report ID: 3620
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Buy Now

Zoster Treatment Market Trends

Growth Drivers

High Prevalence of Zoster Globally
Rising Introduction of Vaccines and Medications for Self-Treatment

Challenges

High Cost of Treatment of Zoster

Zoster Treatment Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	13.8%
Base Year Market Size (2023)	USD 4.6 billion
Forecast Year Market Size (2036)	USD 30.6 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Zoster Treatment Market Size & Share | Growth Trends 2036

Author Credits: Radhika Pawar

Report ID: 3620
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving market growth are high prevalence of zoster globally and rising introduction of vaccines and medications for self-treatment.

The market is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2022 â€“ 2030.

High cost of zoster treatment is estimated to hamper the market growth.

Asia Pacific will provide more business opportunities for market growth owing to the growing occurrence of herpes zoster, and rising initiatives by governmental and non-governmental organizations associated with vaccination drives.

The major players in the market are Valeant Pharmaceuticals North America, LLC, Merck & Co., Inc., Abbott Laboratories, Teva Pharmaceutical Ltd, and others.

Inquiry Before Buying Request Free Sample